Cryoablation Within the Evolving Paradigm of Multidisciplinary Breast Cancer Treatment De-Escalation

Study limitation reported by the research below: “The impact flag 'practice changing' is applied cautiously: the FDA approval and guideline update represent a meaningful shift, but only for a specific and narrow patient population (women ≥70 with early-stage, low-risk disease).”